Schor Chen
Karyopharm Therapeutics Inc. · Director
Schor Chen is listed in filings as Director at Karyopharm Therapeutics Inc.. This profile follows SEC Form 4 activity through May 26, 2026, including 2 public disclosures. Recent filings connect the profile to Karyopharm Therapeutics Inc. (KPTI). The current snapshot covers public activity from May 29, 2025 to May 26, 2026. Reported amounts are shown as $20.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||